Home > Boards > US OTC > Food - Beverages > MusclePharm Corporation (MSLP)

Ryan Drexler, President and Chief Executive Officer, stated,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
turokman Member Profile
 
Followed By 18
Posts 3,742
Boards Moderated 1
Alias Born 10/12/11
160x600 placeholder
MusclePharm names former Yum! Brands C-suite executive as CFO and President Seeking Alpha - 4/8/2021 12:48:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/7/2021 5:16:20 PM
MusclePharm reports Q4 results Seeking Alpha - 3/30/2021 10:56:59 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/29/2021 5:19:53 PM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/26/2021 5:17:27 PM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/26/2021 5:16:21 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/29/2021 12:04:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/25/2021 6:02:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 6:04:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/22/2020 5:00:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/3/2020 12:53:08 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 12/2/2020 4:58:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/1/2020 5:01:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/1/2020 12:51:19 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/24/2020 6:05:03 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/24/2020 6:03:49 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/24/2020 6:03:43 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 10/28/2020 3:58:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/1/2020 4:16:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2020 4:36:31 PM
Annual Report (10-k) Edgar (US Regulatory) - 8/25/2020 9:31:11 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/25/2020 9:30:40 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/25/2020 9:29:33 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/25/2020 9:28:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2020 4:35:36 PM
turokman   Thursday, 12/31/20 06:31:05 AM
Re: None
Post # of 80574 
Ryan Drexler, President and Chief Executive Officer, stated, “Our management team has spent the last two years dramatically restructuring MusclePharm and are now generating positive cash flow and well positioned for long-term profitable growth even in the current COVID-19 pandemic environment. The business turnaround was driven by reducing low margin sales into inefficient channels, increasing gross margins, decreasing operating expenses and improving our overall EBITDA. We have many of the leading brands in nutrition but we needed to do a much better job of realizing the value of our brands by reducing product discounts and being more efficient in our promotional activity, reducing SKU’s that are not properly positioned, and better aligning our operations with repositioned top-line growth.


$MSLP

http://ir.musclepharmcorp.com/prviewer/release_only/id/4548989




$MSLP - Every Dog Has Its Day .
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences